aluates Reports

$ 0.0

Automative

Global Sevoflurane Market Research Report 2026

Published Date: 2026-01-15

Report Code: QYRE-Auto-30X8684

BUY CHAPTERS

Global Sevoflurane Market Research Report 2026

Code: QYRE-Auto-30X8684

Report

2026-01-15

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Baxter

Maruishi

Hengrui

AbbVie

Piramal

Viatris

PT Novell Pharmaceutical

Lunan Pharma

Sevoflurane Market Size

The global Sevoflurane market was valued at US$ 1234 million in 2025 and is anticipated to reach US$ 1577 million by 2032, at a CAGR of 3.6% from 2026 to 2032.

Sevoflurane Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sevoflurane competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.

The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.

One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.

This report delivers a comprehensive overview of the global Sevoflurane market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sevoflurane. The Sevoflurane market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Sevoflurane market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Sevoflurane manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Sevoflurane Market Report

Report Metric	Details
Report Name	Sevoflurane Market
Accounted market size in 2025	US$ 1234 million
Forecasted market size in 2032	US$ 1577 million
CAGR	3.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Generic Drug Original Drug
by Application	Hospital Clinics Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Hengrui, Baxter, Maruishi, AbbVie, Piramal, Viatris, PT Novell Pharmaceutical, Lunan Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Sevoflurane manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Sevoflurane sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Sevoflurane Market growing?

Ans: The Sevoflurane Market witnessing a CAGR of 3.6% during the forecast period 2026-2032.

What is the Sevoflurane Market size in 2032?

Ans: The Sevoflurane Market size in 2032 will be US$ 1577 million.

Who are the main players in the Sevoflurane Market report?

Ans: The main players in the Sevoflurane Market are Hengrui, Baxter, Maruishi, AbbVie, Piramal, Viatris, PT Novell Pharmaceutical, Lunan Pharma

What are the Application segmentation covered in the Sevoflurane Market report?

Ans: The Applications covered in the Sevoflurane Market report are Hospital, Clinics, Other

What are the Type segmentation covered in the Sevoflurane Market report?

Ans: The Types covered in the Sevoflurane Market report are Generic Drug, Original Drug

1 Sevoflurane Market Overview

1.1 Product Definition

1.2 Sevoflurane by Type

1.2.1 Global Sevoflurane Market Value by Type: 2025 vs 2032

1.2.2 Generic Drug

1.2.3 Original Drug

1.3 Sevoflurane by Application

1.3.1 Global Sevoflurane Market Value by Application: 2025 vs 2032

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Other

1.4 Global Sevoflurane Market Size Estimates and Forecasts

1.4.1 Global Sevoflurane Revenue 2021–2032

1.4.2 Global Sevoflurane Sales 2021–2032

1.4.3 Global Sevoflurane Market Average Price (2021–2032)

1.5 Assumptions and Limitations

2 Sevoflurane Market Competition by Manufacturers

2.1 Global Sevoflurane Sales Market Share by Manufacturers (2021–2026)

2.2 Global Sevoflurane Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Sevoflurane Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Sevoflurane, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Sevoflurane, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Sevoflurane, Product Types and Applications

2.7 Global Key Manufacturers of Sevoflurane, Date of Entry into the Industry

2.8 Global Sevoflurane Market Competitive Situation and Trends

2.8.1 Global Sevoflurane Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Sevoflurane Players Market Share by Revenue

2.8.3 Global Sevoflurane Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Sevoflurane Market Scenario by Region

3.1 Global Sevoflurane Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Sevoflurane Sales by Region: 2021–2032

3.2.1 Global Sevoflurane Sales by Region: 2021–2026

3.2.2 Global Sevoflurane Sales by Region: 2027–2032

3.3 Global Sevoflurane Revenue by Region: 2021–2032

3.3.1 Global Sevoflurane Revenue by Region: 2021–2026

3.3.2 Global Sevoflurane Revenue by Region: 2027–2032

3.4 North America Sevoflurane Market Facts & Figures by Country

3.4.1 North America Sevoflurane Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Sevoflurane Sales by Country (2021–2032)

3.4.3 North America Sevoflurane Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Sevoflurane Market Facts & Figures by Country

3.5.1 Europe Sevoflurane Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Sevoflurane Sales by Country (2021–2032)

3.5.3 Europe Sevoflurane Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Sevoflurane Market Facts & Figures by Region

3.6.1 Asia Pacific Sevoflurane Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Sevoflurane Sales by Region (2021–2032)

3.6.3 Asia Pacific Sevoflurane Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Sevoflurane Market Facts & Figures by Country

3.7.1 Latin America Sevoflurane Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Sevoflurane Sales by Country (2021–2032)

3.7.3 Latin America Sevoflurane Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Sevoflurane Market Facts & Figures by Country

3.8.1 Middle East and Africa Sevoflurane Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Sevoflurane Sales by Country (2021–2032)

3.8.3 Middle East and Africa Sevoflurane Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Sevoflurane Sales by Type (2021–2032)

4.1.1 Global Sevoflurane Sales by Type (2021–2026)

4.1.2 Global Sevoflurane Sales by Type (2027–2032)

4.1.3 Global Sevoflurane Sales Market Share by Type (2021–2032)

4.2 Global Sevoflurane Revenue by Type (2021–2032)

4.2.1 Global Sevoflurane Revenue by Type (2021–2026)

4.2.2 Global Sevoflurane Revenue by Type (2027–2032)

4.2.3 Global Sevoflurane Revenue Market Share by Type (2021–2032)

4.3 Global Sevoflurane Price by Type (2021–2032)

5 Segment by Application

5.1 Global Sevoflurane Sales by Application (2021–2032)

5.1.1 Global Sevoflurane Sales by Application (2021–2026)

5.1.2 Global Sevoflurane Sales by Application (2027–2032)

5.1.3 Global Sevoflurane Sales Market Share by Application (2021–2032)

5.2 Global Sevoflurane Revenue by Application (2021–2032)

5.2.1 Global Sevoflurane Revenue by Application (2021–2026)

5.2.2 Global Sevoflurane Revenue by Application (2027–2032)

5.2.3 Global Sevoflurane Revenue Market Share by Application (2021–2032)

5.3 Global Sevoflurane Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Hengrui

6.1.1 Hengrui Company Information

6.1.2 Hengrui Description and Business Overview

6.1.3 Hengrui Sevoflurane Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Hengrui Sevoflurane Product Portfolio

6.1.5 Hengrui Recent Developments/Updates

6.2 Baxter

6.2.1 Baxter Company Information

6.2.2 Baxter Description and Business Overview

6.2.3 Baxter Sevoflurane Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Baxter Sevoflurane Product Portfolio

6.2.5 Baxter Recent Developments/Updates

6.3 Maruishi

6.3.1 Maruishi Company Information

6.3.2 Maruishi Description and Business Overview

6.3.3 Maruishi Sevoflurane Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Maruishi Sevoflurane Product Portfolio

6.3.5 Maruishi Recent Developments/Updates

6.4 AbbVie

6.4.1 AbbVie Company Information

6.4.2 AbbVie Description and Business Overview

6.4.3 AbbVie Sevoflurane Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 AbbVie Sevoflurane Product Portfolio

6.4.5 AbbVie Recent Developments/Updates

6.5 Piramal

6.5.1 Piramal Company Information

6.5.2 Piramal Description and Business Overview

6.5.3 Piramal Sevoflurane Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Piramal Sevoflurane Product Portfolio

6.5.5 Piramal Recent Developments/Updates

6.6 Viatris

6.6.1 Viatris Company Information

6.6.2 Viatris Description and Business Overview

6.6.3 Viatris Sevoflurane Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Viatris Sevoflurane Product Portfolio

6.6.5 Viatris Recent Developments/Updates

6.7 PT Novell Pharmaceutical

6.7.1 PT Novell Pharmaceutical Company Information

6.7.2 PT Novell Pharmaceutical Description and Business Overview

6.7.3 PT Novell Pharmaceutical Sevoflurane Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 PT Novell Pharmaceutical Sevoflurane Product Portfolio

6.7.5 PT Novell Pharmaceutical Recent Developments/Updates

6.8 Lunan Pharma

6.8.1 Lunan Pharma Company Information

6.8.2 Lunan Pharma Description and Business Overview

6.8.3 Lunan Pharma Sevoflurane Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Lunan Pharma Sevoflurane Product Portfolio

6.8.5 Lunan Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Sevoflurane Industry Chain Analysis

7.2 Sevoflurane Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Sevoflurane Production Mode & Process Analysis

7.4 Sevoflurane Sales and Marketing

7.4.1 Sevoflurane Sales Channels

7.4.2 Sevoflurane Distributors

7.5 Sevoflurane Customer Analysis

8 Sevoflurane Market Dynamics

8.1 Sevoflurane Industry Trends

8.2 Sevoflurane Market Drivers

8.3 Sevoflurane Market Challenges

8.4 Sevoflurane Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Baxter

Maruishi

Hengrui

AbbVie

Piramal

Viatris

PT Novell Pharmaceutical

Lunan Pharma

List of Tables

Table 1. Global Sevoflurane Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Sevoflurane Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Sevoflurane Market Competitive Situation by Manufacturers in 2025

Table 4. Global Sevoflurane Sales (K Units) of Key Manufacturers (2021–2026)

Table 5. Global Sevoflurane Sales Market Share by Manufacturers (2021–2026)

Table 6. Global Sevoflurane Revenue (US$ Million) by Manufacturers (2021–2026)

Table 7. Global Sevoflurane Revenue Share by Manufacturers (2021–2026)

Table 8. Global Market Sevoflurane Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 9. Global Key Players of Sevoflurane, Industry Ranking, 2023 vs 2024 vs 2025

Table 10. Global Key Manufacturers of Sevoflurane, Manufacturing Sites and Headquarters

Table 11. Global Key Manufacturers of Sevoflurane, Product Types and Applications

Table 12. Global Key Manufacturers of Sevoflurane, Date of Entry into the Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Sevoflurane Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sevoflurane Revenue, 2025

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Sevoflurane Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Sevoflurane Sales by Region (K Units), 2021–2026

Table 18. Global Sevoflurane Sales Market Share by Region (2021–2026)

Table 19. Global Sevoflurane Sales by Region (K Units), 2027–2032

Table 20. Global Sevoflurane Sales Market Share by Region (2027–2032)

Table 21. Global Sevoflurane Revenue by Region (US$ Million), 2021–2026

Table 22. Global Sevoflurane Revenue Market Share by Region (2021–2026)

Table 23. Global Sevoflurane Revenue by Region (US$ Million), 2027–2032

Table 24. Global Sevoflurane Revenue Market Share by Region (2027–2032)

Table 25. North America Sevoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 26. North America Sevoflurane Sales by Country (K Units), 2021–2026

Table 27. North America Sevoflurane Sales by Country (K Units), 2027–2032

Table 28. North America Sevoflurane Revenue by Country (US$ Million), 2021–2026

Table 29. North America Sevoflurane Revenue by Country (US$ Million), 2027–2032

Table 30. Europe Sevoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 31. Europe Sevoflurane Sales by Country (K Units), 2021–2026

Table 32. Europe Sevoflurane Sales by Country (K Units), 2027–2032

Table 33. Europe Sevoflurane Revenue by Country (US$ Million), 2021–2026

Table 34. Europe Sevoflurane Revenue by Country (US$ Million), 2027–2032

Table 35. Asia Pacific Sevoflurane Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 36. Asia Pacific Sevoflurane Sales by Region (K Units), 2021–2026

Table 37. Asia Pacific Sevoflurane Sales by Region (K Units), 2027–2032

Table 38. Asia Pacific Sevoflurane Revenue by Region (US$ Million), 2021–2026

Table 39. Asia Pacific Sevoflurane Revenue by Region (US$ Million), 2027–2032

Table 40. Latin America Sevoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 41. Latin America Sevoflurane Sales by Country (K Units), 2021–2026

Table 42. Latin America Sevoflurane Sales by Country (K Units), 2027–2032

Table 43. Latin America Sevoflurane Revenue by Country (US$ Million), 2021–2026

Table 44. Latin America Sevoflurane Revenue by Country (US$ Million), 2027–2032

Table 45. Middle East and Africa Sevoflurane Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 46. Middle East and Africa Sevoflurane Sales by Country (K Units), 2021–2026

Table 47. Middle East and Africa Sevoflurane Sales by Country (K Units), 2027–2032

Table 48. Middle East and Africa Sevoflurane Revenue by Country (US$ Million), 2021–2026

Table 49. Middle East and Africa Sevoflurane Revenue by Country (US$ Million), 2027–2032

Table 50. Global Sevoflurane Sales (K Units) by Type (2021–2026)

Table 51. Global Sevoflurane Sales (K Units) by Type (2027–2032)

Table 52. Global Sevoflurane Sales Market Share by Type (2021–2026)

Table 53. Global Sevoflurane Sales Market Share by Type (2027–2032)

Table 54. Global Sevoflurane Revenue (US$ Million) by Type (2021–2026)

Table 55. Global Sevoflurane Revenue (US$ Million) by Type (2027–2032)

Table 56. Global Sevoflurane Revenue Market Share by Type (2021–2026)

Table 57. Global Sevoflurane Revenue Market Share by Type (2027–2032)

Table 58. Global Sevoflurane Price (US$/Unit) by Type (2021–2026)

Table 59. Global Sevoflurane Price (US$/Unit) by Type (2027–2032)

Table 60. Global Sevoflurane Sales (K Units) by Application (2021–2026)

Table 61. Global Sevoflurane Sales (K Units) by Application (2027–2032)

Table 62. Global Sevoflurane Sales Market Share by Application (2021–2026)

Table 63. Global Sevoflurane Sales Market Share by Application (2027–2032)

Table 64. Global Sevoflurane Revenue (US$ Million) by Application (2021–2026)

Table 65. Global Sevoflurane Revenue (US$ Million) by Application (2027–2032)

Table 66. Global Sevoflurane Revenue Market Share by Application (2021–2026)

Table 67. Global Sevoflurane Revenue Market Share by Application (2027–2032)

Table 68. Global Sevoflurane Price (US$/Unit) by Application (2021–2026)

Table 69. Global Sevoflurane Price (US$/Unit) by Application (2027–2032)

Table 70. Hengrui Company Information

Table 71. Hengrui Description and Business Overview

Table 72. Hengrui Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 73. Hengrui Sevoflurane Product

Table 74. Hengrui Recent Developments/Updates

Table 75. Baxter Company Information

Table 76. Baxter Description and Business Overview

Table 77. Baxter Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 78. Baxter Sevoflurane Product

Table 79. Baxter Recent Developments/Updates

Table 80. Maruishi Company Information

Table 81. Maruishi Description and Business Overview

Table 82. Maruishi Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 83. Maruishi Sevoflurane Product

Table 84. Maruishi Recent Developments/Updates

Table 85. AbbVie Company Information

Table 86. AbbVie Description and Business Overview

Table 87. AbbVie Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 88. AbbVie Sevoflurane Product

Table 89. AbbVie Recent Developments/Updates

Table 90. Piramal Company Information

Table 91. Piramal Description and Business Overview

Table 92. Piramal Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 93. Piramal Sevoflurane Product

Table 94. Piramal Recent Developments/Updates

Table 95. Viatris Company Information

Table 96. Viatris Description and Business Overview

Table 97. Viatris Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 98. Viatris Sevoflurane Product

Table 99. Viatris Recent Developments/Updates

Table 100. PT Novell Pharmaceutical Company Information

Table 101. PT Novell Pharmaceutical Description and Business Overview

Table 102. PT Novell Pharmaceutical Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 103. PT Novell Pharmaceutical Sevoflurane Product

Table 104. PT Novell Pharmaceutical Recent Developments/Updates

Table 105. Lunan Pharma Company Information

Table 106. Lunan Pharma Description and Business Overview

Table 107. Lunan Pharma Sevoflurane Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 108. Lunan Pharma Sevoflurane Product

Table 109. Lunan Pharma Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Sevoflurane Distributors List

Table 113. Sevoflurane Customers List

Table 114. Sevoflurane Market Trends

Table 115. Sevoflurane Market Drivers

Table 116. Sevoflurane Market Challenges

Table 117. Sevoflurane Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Sevoflurane

Figure 2. Global Sevoflurane Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Sevoflurane Market Share by Type: 2025 & 2032

Figure 4. Generic Drug Product Picture

Figure 5. Original Drug Product Picture

Figure 6. Global Sevoflurane Market Value by Application (US$ Million), 2021–2032

Figure 7. Global Sevoflurane Market Share by Application: 2025 & 2032

Figure 8. Hospital

Figure 9. Clinics

Figure 10. Other

Figure 11. Global Sevoflurane Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global Sevoflurane Market Size (US$ Million), 2021–2032

Figure 13. Global Sevoflurane Sales (K Units), 2021–2032

Figure 14. Global Sevoflurane Average Price (US$/Unit), 2021–2032

Figure 15. Sevoflurane Report Years Considered

Figure 16. Sevoflurane Sales Share by Manufacturers in 2025

Figure 17. Global Sevoflurane Revenue Share by Manufacturers in 2025

Figure 18. Top 5 and Top 10 Global Sevoflurane Players: Market Share by Revenue in Sevoflurane in 2025

Figure 19. Sevoflurane Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 20. Global Sevoflurane Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 21. North America Sevoflurane Sales Market Share by Country (2021–2032)

Figure 22. North America Sevoflurane Revenue Market Share by Country (2021–2032)

Figure 23. U.S. Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 24. Canada Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 25. Europe Sevoflurane Sales Market Share by Country (2021–2032)

Figure 26. Europe Sevoflurane Revenue Market Share by Country (2021–2032)

Figure 27. Germany Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 28. France Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. U.K. Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Italy Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 31. Russia Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 32. Asia Pacific Sevoflurane Sales Market Share by Region (2021–2032)

Figure 33. Asia Pacific Sevoflurane Revenue Market Share by Region (2021–2032)

Figure 34. China Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Japan Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. South Korea Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. India Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Australia Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Taiwan Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Indonesia Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Thailand Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Malaysia Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Philippines Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Latin America Sevoflurane Sales Market Share by Country (2021–2032)

Figure 45. Latin America Sevoflurane Revenue Market Share by Country (2021–2032)

Figure 46. Mexico Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Brazil Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Argentina Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Middle East and Africa Sevoflurane Sales Market Share by Country (2021–2032)

Figure 50. Middle East and Africa Sevoflurane Revenue Market Share by Country (2021–2032)

Figure 51. Turkey Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Saudi Arabia Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. U.A.E Sevoflurane Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Global Sales Market Share of Sevoflurane by Type (2021–2032)

Figure 55. Global Revenue Market Share of Sevoflurane by Type (2021–2032)

Figure 56. Global Sevoflurane Price (US$/Unit) by Type (2021–2032)

Figure 57. Global Sales Market Share of Sevoflurane by Application (2021–2032)

Figure 58. Global Revenue Market Share of Sevoflurane by Application (2021–2032)

Figure 59. Global Sevoflurane Price (US$/Unit) by Application (2021–2032)

Figure 60. Sevoflurane Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sevoflurane Sevoflurane Source Market Research Report 2024

Global Sevoflurane Anesthesia Drugs Market Research Report 2024

Global Inhalation Sevoflurane Anesthesia Drugs Market Research Report 2024

Global Sevoflurane For Inhalation Market Research Report 2024

Global Sevoflurane Source Market Insights Forecast to 2030

Global Desflurane Market Research Report 2024

Inhalation Sevoflurane Anaesthetic Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inhalation General Anesthesia Drugs Market Research Report 2024

Global Inhalation Anesthesia Drugs Market Research Report 2024

Global Anesthesia Gas Market Research Report 2024

Global Isoflurane Anesthesia Drugs Market Research Report 2024

Global Inhalational Isoflurane Market Research Report 2024

Sevoflurane Anesthesia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inhalational Anaesthesia Drugs Market Research Report 2024

Global Inhalation Sedatives Market Research Report 2024

Global Sevoflurane and Desflurane Anaesthetics Market Research Report 2025

Global Sevoflurane Anesthesia Vaporizers Market Research Report 2024

Global General Anesthesia Drugs Market Research Report 2025

Global Medical Sevofluran Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions